Perspective: improving vitamin D status in the management of COVID-19

被引:113
作者
Ebadi, Maryam [1 ,2 ]
Montano-Loza, Aldo J. [1 ,2 ]
机构
[1] Univ Alberta Hosp, Div Gastroenterol, Edmonton, AB, Canada
[2] Univ Alberta Hosp, Liver Unit, Edmonton, AB, Canada
关键词
D DEFICIENCY; PREVALENCE;
D O I
10.1038/s41430-020-0661-0
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
[No abstract available]
引用
收藏
页码:856 / 859
页数:4
相关论文
共 35 条
[31]  
Tabrizi R, 2018, IRAN J MED SCI, V43, P125
[32]  
Wacker M, 2013, DERM-ENDOCRINOL, V5, DOI [10.4161/derm.24476, 10.4161/derm.24494]
[33]   Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system [J].
Xu, Jun ;
Yang, Jialai ;
Chen, Jian ;
Luo, Qingli ;
Zhang, Qiu ;
Zhang, Hong .
MOLECULAR MEDICINE REPORTS, 2017, 16 (05) :7432-7438
[34]   COVID-19 and African Americans [J].
Yancy, Clyde W. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (19) :1891-1892
[35]   Vitamin D Deficiency as a Potential Marker of Benign Prostatic Hyperplasia [J].
Zhang, Weibing ;
Zheng, Xinmin ;
Wang, Yongzhi ;
Xiao, He .
UROLOGY, 2016, 97 :212-217